Trending
- A plasma derived hypoxia signature predicts benefit from hypoxia-modifying radiotherapy and reveals dynamic humoral immune modulation in bladder cancer
- Iberdomide Triplet Improves MRD-Negative CRs in R/R Multiple Myeloma
- How Academic/Community Oncologists Improve Access to New Myeloma Therapies
- BRCA1/2 variant profiling and HPV/HMTV DNA detection in a cohort of Egyptian women with breast cancer
- Defining the Role of Neoadjuvant Radiation in Cholangiocarcinoma
- Managing Sustained MRD Negativity After Multiple Myeloma Therapy Ends
- PERSEUS Trial Shows Daratumumab Regimen Deepens Responses in NDMM
- Etentamig Shows Superior Efficacy vs SOC in Relapsed/Refractory Myeloma
